(5-amino-1-phenyl-1H-pyrazol-4-yl)(1H-indol-3-yl)methanone, 95.0%, 500mg

1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone, 98%, 250mg

1-Cyclobutyl-piperazine, 98.0%, 1g

N'-(4-chloro-1,3-benzothiazol-2-yl)-N,N-dimethylpropane-1,3-diamine, 95.0%, 250mg

2,3,6-Trichloro-4-(trifluoromethyl)pyridine, 95+%, 1g

2-Hydroxy-4-iodobenzaldehyde, 95.0%, 250mg

2-(2-Chloro-acetylamino)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid ethyl ester, 95.0%, 250mg

2,5-Dibromo-3-tetradecylthiophene>97.0%(GC)5g

Accessories Release spring For ROTILABO® microliter pipettes, 1 piece

2-(2,2,2-Trifluoro-1-phenyl-ethyl)-piperidine, 5g

METHYL 3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE-5-CARBOXYLATE, 95.0%, 100mg

1-Bromo-4-(bromomethyl)-2-methylbenzene, 95.0%, 25g

2-Chloro-N-methylpyrimidin-4-amine, 97.0%, 10g